Will Morgan Stanley's Q2 2026 reported EPS exceed consensus estimates by at least $0.05?

Q1 2026 was a +13.6% EPS blowout, which historically triggers sell-side estimate revisions that overshoot by 2-4 percentage points of beat probability for the next quarter. With stock at $194.59 52-week high, analysts face strong pressure to raise. Q2 2025 base ($2.13) is favorable for growth optics but consensus will reset higher. Lean YES modestly.

Tail-risk frame: Q2 first full quarter under DCP-derivative hedging transition; advisory pop in Q1 (+74% YoY) likely flushed pent-up backlog reducing Q2 momentum; tax rate likely reverts toward 22-23% guide eliminating Q1's low-tax tailwind. These three Q2-specific headwinds cluster against a tightened consensus. Coin-flip.

Second-order: management tradition of conservative guide + buyback share-count reduction continuing + NII guided to modest Q2 increase + Wealth fee-based momentum supports beat. The $0.05 threshold is small relative to the typical $0.10-0.20 beat magnitude. Slight lean YES.

Base rate ~70% beat, adjusted down ~15 pts for post-blowout estimate compression and the higher consensus floor. Wealth momentum and ISG records support; tax rate reversion offsets. Around 55%.

After a blowout quarter, sell-side rebalances. Q1 2026 was the 7th beat in 8 quarters but +13.6% magnitude is unusual — analysts raised Q2 estimates aggressively. Coin-flip with slight YES tilt.

True 50/50. Q2 has multiple competing forces: DCP completed (neutral), tax reverts (negative), Wealth momentum (positive), IB advisory comp tougher (negative). Net flat.

MS beats consistently; threshold modest. Lean YES at 58%.

Strong Q1 momentum suggests Q2 follow-through, but analysts will raise. Moderate YES at 55%.

Beat history strong but post-blowout consensus is taut. Slight YES at 53%.